OTC · Drug Manufacturers - Specialty & Generic

Elixxer Ltd. (ELIXF) Stock

$0.03 +0.00% OTC: ELIXF Healthcare

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry.

Valuation

MetricValue
Price$0.03
Market Cap$23.35M
P/E Ratio-0.14
P/B Ratio-0.05
P/S Ratio0.00
EPS (TTM)$-0.34
52-Week High$0.10
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE29.22%
ROA-364.36%
ROCE6.64%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.98
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-3.0M$-1.0M$0$-1.0M
Net Profit$-4.0M$-23.0M$0$0$-4.0M
EPS$-0.42$-2.09$0.00$0.00$-0.34
Op Margin-4974.0%-2274.6%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.0M$5.0M$5.0M$2.0M$1.0M
Total Liabilities$9.0M$11.0M$21.0M$15.0M$11.0M
Cash$0$0$0$0$0
Borrowings$7.0M$8.0M$16.0M$12.0M$10.0M

Latest News

Elixxer Announces Adoption of Semi-Annual Reporting TMX Newsfile · May 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-4.0M$-4.0M$0$-1.0M
Investing Cash Flow$2.0M$2.0M$4.0M$0$0
Financing Cash Flow$0$-1.0M$0$0$0
Net Cash Flow$-2.0M$0$0$0$0
Free Cash Flow$-4.0M$-4.0M$-4.0M$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-64.23
FCF Yield-2.14%
Quick Ratio0.00
Interest Coverage-0.56
Return 1Y2476.92%
Return 3Y1.82%
Return 5Y—

Ownership

Insiders Held3.66%
Institutions Held84.28%
Institutions Float Held87.48%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANSFAtlas Energy Corp. $0.09 +0.00% -2.10 $30.64M 0.00%
CXXIFC21 Investments Inc. $0.21 -3.53% -9.40 $24.33M 0.00%
DXBRFBellRock Brands Inc. $0.00 — 0.00 $53153 0.00%
FLOOFFlower One Holdings Inc. $0.00 — -0.03 $4731 0.00%
MILFF1CM Inc. $0.10 +0.00% 3.27 $12.06M 0.00%

About Elixxer Ltd.

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.

Elixxer Ltd. is headquartered in CA.

Elixxer Ltd. (ELIXF) stock trades at $0.03 with a market capitalization of $23.35M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of -0.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 70.0% below its 52-week high.

On profitability, Elixxer Ltd. generates a return on equity (ROE) of 29.22% — well above the market average, a sign of a high-quality business, return on capital employed of 6.64%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.elixxer.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides